Another drug named nivolumab (Opdivo, Opdyta) performs antagonist action on Programmed Cell Death Protein 1 (PD1 or CD279 or PDCD1) and is a human IgG4 anti PD-1 monoclonal antibody that treats hepatocellular carcinoma. Here, PDCD1 is linked to hepatocellular carcinoma.